Cancer Management and Research (May 2022)
Baseline Serum Cholesterol Levels Predict the Response of Patients with Advanced Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitor-Based Treatment [Corrigendum]
Abstract
Tong III J, Mao Y, Yang Z, et al. Cancer Manag Res. 2021;13:4041–4053. The authors have advised due to an error at the time of figure assembly, Figure 2D on page 4048 is incorrect. The correct Figure 2 is shown in Download Article: The authors apologize for this error and advise it does not affect the results of the paper. Read the original article